USP12 | Ubiquitin specific peptidase 12 | Enzymes
| | | | | Expressed in all |
RPL21 | Ribosomal protein L21 | Disease related genes Ribosomal proteins
| | | | | Expressed in all |
RASL11A | RAS-like, family 11, member A | | | | | | Expressed in all |
GTF3A | General transcription factor IIIA | Transcription factors
| | | | | Expressed in all |
MTIF3 | Mitochondrial translational initiation factor 3 | Mitochondrial proteins
| | | | | Expressed in all |
LNX2 | Ligand of numb-protein X 2 | Plasma proteins
| | | | | Expressed in all |
POLR1D | Polymerase (RNA) I polypeptide D, 16kDa | Disease related genes RNA polymerase related proteins
| | | | | Expressed in all |
GSX1 | GS homeobox 1 | Transcription factors
| | | | | Not detected |
PDX1 | Pancreatic and duodenal homeobox 1 | Disease related genes Transcription factors
| | | | | Tissue enriched |
ATP5EP2 | ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit pseudogene 2 | | | | | | Expressed in all |
CDX2 | Caudal type homeobox 2 | Cancer-related genes Transcription factors
| | | | | Group enriched |
URAD | Ureidoimidazoline (2-oxo-4-hydroxy-4-carboxy-5-) decarboxylase | Enzymes
| | | | | Tissue enhanced |
FLT3 | Fms-related tyrosine kinase 3 | Cancer-related genes CD markers Disease related genes Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Mixed |
PAN3 | PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) | | | | | | Expressed in all |
FLT1 | Fms-related tyrosine kinase 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enriched |
POMP | Proteasome maturation protein | Disease related genes
| | | | | Expressed in all |
SLC46A3 | Solute carrier family 46, member 3 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
MTUS2 | Microtubule associated tumor suppressor candidate 2 | | | | | | Tissue enriched |
SLC7A1 | Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 | Predicted membrane proteins Transporters
| | | | | Mixed |
UBL3 | Ubiquitin-like 3 | | | | | | Expressed in all |
KATNAL1 | Katanin p60 subunit A-like 1 | Enzymes
| | | | | Mixed |
HMGB1 | High mobility group box 1 | Plasma proteins
| | | | | Expressed in all |
USPL1 | Ubiquitin specific peptidase like 1 | Enzymes
| | | | | Expressed in all |
ALOX5AP | Arachidonate 5-lipoxygenase-activating protein | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
MEDAG | Mesenteric estrogen-dependent adipogenesis | | | | | | Tissue enhanced |
TEX26 | Testis expressed 26 | | | | | | Tissue enriched |
HSPH1 | Heat shock 105kDa/110kDa protein 1 | Cancer-related genes
| | | | | Expressed in all |
B3GALTL | Beta 1,3-galactosyltransferase-like | Disease related genes Predicted secreted proteins
| | | | | Expressed in all |
RXFP2 | Relaxin/insulin-like family peptide receptor 2 | Disease related genes G-protein coupled receptors Potential drug targets Predicted membrane proteins
| | | | | Not detected |
FRY | Furry homolog (Drosophila) | | | | | | Expressed in all |
ZAR1L | Zygote arrest 1-like | | | | | | Not detected |
BRCA2 | Breast cancer 2, early onset | Cancer-related genes Disease related genes
| | | | | Mixed |
N4BP2L1 | NEDD4 binding protein 2-like 1 | | | | | | Expressed in all |
N4BP2L2 | NEDD4 binding protein 2-like 2 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
PDS5B | PDS5, regulator of cohesion maintenance, homolog B (S. cerevisiae) | | | | | | Expressed in all |
KL | Klotho | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enriched |
STARD13 | StAR-related lipid transfer (START) domain containing 13 | Mitochondrial proteins Plasma proteins
| | | | | Mixed |
RFC3 | Replication factor C (activator 1) 3, 38kDa | | | | | | Expressed in all |
NBEA | Neurobeachin | Plasma proteins Predicted membrane proteins
| | | | | Mixed |
MAB21L1 | Mab-21-like 1 (C. elegans) | | | | | | Tissue enhanced |
DCLK1 | Doublecortin-like kinase 1 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
SOHLH2 | Spermatogenesis and oogenesis specific basic helix-loop-helix 2 | Transcription factors
| | | | | Tissue enriched |
CCDC169-SOHLH2 | CCDC169-SOHLH2 readthrough | | | | | | Tissue enriched |
CCDC169 | Coiled-coil domain containing 169 | | | | | | Tissue enriched |
SPG20 | Spastic paraplegia 20 (Troyer syndrome) | Disease related genes
| | | | | Expressed in all |
SPG20OS | SPG20 opposite strand | | | | | | Mixed |
CCNA1 | Cyclin A1 | Cancer-related genes
| | | | | Group enriched |
SERTM1 | Serine-rich and transmembrane domain containing 1 | Predicted membrane proteins
| | | | | Group enriched |
RFXAP | Regulatory factor X-associated protein | Disease related genes Transcription factors
| | | | | Expressed in all |
SMAD9 | SMAD family member 9 | Disease related genes Transcription factors
| | | | | Tissue enhanced |